[{"AccountsPayableCurrent_0_Q1_USD":3704000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2485000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_1_Q1_USD":-3161000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":60675000.0,"RestrictedCashCurrent_0_Q1_USD":10000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":5.01,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-10000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":913000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":16200000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q1_USD":11616000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1_Q1_USD":-700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":2200000.0,"InvestmentIncomeInterest_1_Q1_USD":526000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":162000.0,"IncomeTaxesReceivable_0_Q1_USD":153000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":217000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":1082000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":328000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1_Q1_shares":9338.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-19752000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":58728000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1_Q1_shares":131147.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":300300000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":136000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":406000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":11.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":2200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":977600.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2048000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":11.9,"DeferredFinanceCostsNet_0_Q1_USD":208000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":10.87,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":406000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":20883000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":338000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5780000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":5616000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1306000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncomeTaxCreditsAndAdjustments_1_Q1_USD":183000.0,"ForeignCurrencyTransactionLossBeforeTax_1_Q1_USD":549000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-72000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":1200000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":20415000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":18630000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":27209000.0,"CapitalizedContractCostNet_0_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2048000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":1731000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":164000.0,"MarketableSecuritiesCurrent_0_Q1_USD":57298000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_1_Q1_shares":52367.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":9.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q1_USD":9.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":279997.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":7.8,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1_Q1_shares":142000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1_Q1_USD":9.35,"AmortizationOfFinancingCosts_1_Q1_USD":21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":4577587.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2167161.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":2200000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":7000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-237741000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1603000.0,"ProfitLoss_1_Q1_USD":-20080000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4716000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":138000.0,"NetIncomeLoss_1_Q1_USD":-20080000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15848000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":42730000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":399000.0,"LiabilitiesCurrent_0_Q1_USD":36372000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":134901000.0,"Liabilities_0_Q1_USD":72235000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-806000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":176000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-19904000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4576000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.72,"DueToRelatedPartiesCurrent_0_Q1_USD":1116000.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":3594000.0,"CommonStockValue_0_Q1_USD":null,"CommonStockSharesOutstanding_0_Q1_shares":27434705.0,"CommonStockSharesIssued_0_Q1_shares":27434705.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":60215000.0,"AssetsCurrent_0_Q1_USD":125986000.0,"Assets_0_Q1_USD":134901000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7651141.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":107000.0,"StockholdersEquity_0_Q1_USD":62666000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":27703918.0,"AccruedLiabilitiesCurrent_0_Q1_USD":11616000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"LongTermDebt_0_Q1_USD":9832000.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q1_pure":0.0977,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":5000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":7.78,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":10.87,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4577587.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-490000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_1_Q1_USD":-146000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":725000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.009,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":29167.0,"ShareBasedCompensation_1_Q1_USD":2048000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":63751000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":18768000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-19697000.0,"OperatingExpenses_1_Q1_USD":23344000.0,"InterestPayableCurrent_0_Q1_USD":68000.0,"InterestExpense_1_Q1_USD":243000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.0785,"DebtInstrumentCarryingAmount_0_Q1_USD":10000000.0,"CommonStockSharesAuthorized_0_Q1_shares":90000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0,"PreferredStockValue_0_Q1_USD":null,"RestrictedCashNoncurrent_0_Q1_USD":450000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]